LifeLabs
LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, BC, and Saskatchewan and performing 112+ million tests annually for 9+ million patients, 60,000+ healthcare providers, employers, hospitals, and pharmaceutical clients. Wholly owned by Quest Diagnostics since August 2024.
- Company typePrivate
- Founded1998
- HeadquartersToronto, Canada
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingServices
What LifeLabs does
LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, British Columbia, and Saskatchewan alongside 16 laboratories including four reference labs, Canada's largest professional genetic testing laboratory (LifeLabs Genetics), a naturopathic lab (Rocky Mountain Analytical), and a digital health connectivity arm (Excelleris). The business is organized around four core divisions - community lab, genetics, naturopathic testing, and digital health - and runs a broad menu spanning routine chemistry, hematology, microbiology, immunology, molecular diagnostics, anatomic pathology, and specialized testing in oncology, prenatal screening, neurology (Alzheimer's p-tau217), nephrology (Klinrisk), and cardiology. The network performs 112+ million tests annually, serves 9+ million patients per year, and supports 60,000+ healthcare providers through EMR-integrated digital platforms including Rover HIE, eOrder, Launchpad, and the MyCareCompass patient portal (5.4+ million registered users).
Revenue is generated through five distinct streams: provincial public reimbursement under OHIP, MSP, and Saskatchewan Health for the bulk of routine testing; out-of-pocket and private-pay pricing for uncovered specialty tests, at-home kits, and MyVisit mobile appointments (CAD $55-$129+ per transaction); corporate and B2B contracts with employers, hospitals, long-term care facilities, and retirement homes; pharmaceutical solutions spanning clinical trials, sponsored testing, patient support programs, companion diagnostics, and Health Insights data services built on a repository of 8.4+ billion de-identified results; and licensing of digital health connectivity platforms to providers and health authorities. Go-to-market is hybrid: a sales-led and partnership motion targeting HCPs, employers, hospitals, LTC, and pharma clients; a direct-to-consumer storefront (store.lifelabs.com) and at-home channel reaching retail patients; and an emerging clinical trials and real-world data distribution arm.
The business is wholly owned by Quest Diagnostics following a CAD $1.35 billion (including net debt) acquisition from OMERS completed in August 2024, and currently operates as a private subsidiary undergoing a multi-phase restructuring that is transferring Ontario reference laboratory specimens to Quest's U.S. facilities beginning April 6, 2026, while continuing to invest in higher-value specialty testing, AI-enabled precision medicine research via the UBC MOSAIC partnership, and event-based diagnostics tied to FIFA World Cup 2026.
LifeLabs firmographics
Firmographics- Name
- LifeLabs
- Legal name
- LifeLabs LP
- Website
- https://lifelabs.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, BC, and Saskatchewan and performing 112+ million tests annually for 9+ million patients, 60,000+ healthcare providers, employers, hospitals, and pharmaceutical clients. Wholly owned by Quest Diagnostics since August 2024.
- Ownership category
- akta.pro rank
LifeLabs industry classification
Industry- Product category
- Medical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
- akta.pro secondary industries
- Reference & Esoteric Testing Laboratories (HLAFAMAJ), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where LifeLabs is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices6 records
Markets served
LifeLabs business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Provincial Public Healthcare Reimbursement: The majority of LifeLabs' diagnostic tests are covered under provincial health insurance plans (OHIP in Ontario, MSP in British Columbia, Saskatchewan Health Services). Individual diagnostic lab tests are covered for members of provincial health insurance, with the provincial government reimbursing LifeLabs for the cost of approved tests.
- Out-of-Pocket / Private Pay Testing: Some tests are not covered by provincial health insurance and are paid directly by patients. These include select specialty tests (e.g., Panorama NIPT, certain genetic tests), at-home collection kits, and MyVisit home appointment services. Pricing ranges from $55 for MyVisit appointments to $129+ for certain tests.
- Corporate/B2B Laboratory Services: LifeLabs provides contracted laboratory testing services to corporate customers including employers (drug & alcohol screening, medical surveillance, employee wellness), hospitals, long-term care facilities, retirement homes, and clinical trial sponsors. Revenue is generated through service contracts and per-test pricing with these institutional clients.
- Pharmaceutical Solutions: LifeLabs offers clinical trials support, sponsored testing programs, patient support program diagnostics, companion diagnostics, and health insights/real world data services to pharmaceutical companies. This includes end-to-end support from clinical development through commercialization.
- Digital Health Solutions Licensing: LifeLabs generates revenue from licensing its digital health platforms (Rover HIE, eOrder, Launchpad EMR viewer, MyCareCompass patient portal) to healthcare providers, health authorities, and pharmaceutical organizations. Services include electronic requisitions, result delivery, and health information exchange.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | MyVisit At-Home Appointment - Select (Flexible Scheduling) |
| Unit Pricing | Pay-as-you-go | MyVisit At-Home Appointment - Standard |
| Unit Pricing | Pay-as-you-go | Pre-Departure COVID-19 PCR/NAAT Testing |
| Unit Pricing | Pay-as-you-go | Fecal Immunochemical Test (FIT) Kit - Patient Direct |
| Unit Pricing | Pay-as-you-go | HPV Self-Collection Kit - Patient Direct |
| Unit Pricing | Pay-as-you-go | Vitamin D At-Home Kit - Patient Direct |
| Unit Pricing | Pay-as-you-go | FIFA World Cup 2026 Medical Screening Services |
| Subscription | Annual | Provincial Health Insurance (OHIP/MSP/Saskatchewan) |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels9 records
LifeLabs product offering
Product offeringCore offering
LifeLabs is Canada's largest community medical diagnostic laboratory network, operating 380+ Patient Service Centres and 16 state-of-the-art laboratories across Ontario, British Columbia, and Saskatchewan. The company performs over 112 million laboratory tests annually for more than 9 million patients, spanning routine clinical chemistry, hematology, microbiology, molecular diagnostics, genetic testing (NIPT, hereditary cancer panels), cardiac monitoring, and specialty oncology testing. It also operates digital health platforms (Rover HIE, eOrder, Launchpad, MyCareCompass) and serves corporate customers including hospitals, employers, long-term care facilities, and pharmaceutical companies.
Product overview
LifeLabs is Canada's largest community laboratory, operating as a unified platform spanning diagnostic testing, genetics, oncology, and digital health across four divisions: LifeLabs (core community lab), LifeLabs Genetics (clinical genetic testing and counselling), Rocky Mountain Analytical (naturopathic testing), and Excelleris (digital connectivity). The company performs over 112 million laboratory tests annually across a network of over 380 Patient Service Centres in Ontario, British Columbia, and Saskatchewan, serving more than 9 million patients and facilitating testing for over 60,000 healthcare providers. The product portfolio centers on core diagnostic services (routine and specialized clinical lab tests), supplemented by advanced oncology products (Signatera MRD, Hereditary Cancer Panel, PSA, FIT), genetic testing (Panorama NIPT, AMH), cardiac monitoring (ECG, Holter, ABPM), and digital health platforms (Rover HIE, eOrder requisition system, Launchpad EMR viewer, MyCareCompass patient portal). LifeLabs' corporate offerings include clinical trials services, pharma solutions (sponsored testing, patient support programs, companion diagnostics, health insights), and employer services (drug screening, medical surveillance, employee wellness). Mobile collection (MyVisit) and Point of Care Testing (POCT) extend laboratory services into non-traditional settings.
Differentiator
Problem solved
Functional benefit
Brands
- Panorama: Non-Invasive Prenatal Test (NIPT) that screens for common genetic conditions caused by extra or missing chromosomes in the baby's DNA, available from 9 weeks gestation.
- Signatera
- MyCareCompass
- MyVisit
- launchpad
- POCT
Products and services
- LifeLabs Core Diagnostic Laboratory Services Core medical diagnostic laboratory services including specimen collection, routine chemistry, hematology, microbiology, immunology, molecular diagnostics, and results reporting for individual patients, healthcare providers, hospitals, and corporate customers. Performs over 112 million tests annually for more than 9 million patients.
- Panorama Non-Invasive Prenatal Test (NIPT) A Non-Invasive Prenatal Test that screens for common genetic conditions caused by extra or missing chromosomes in the baby's DNA as early as 9 weeks, analyzing placental DNA through a simple maternal blood draw.
- Signatera Molecular Residual Disease (MRD) Test A highly sensitive and personalized molecular residual disease (MRD) test using circulating tumor DNA (ctDNA), custom-designed for each patient to help quantify tumour burden and identify relapse earlier than standard of care tools. Appropriate for patients diagnosed with solid tumour cancers.
- Hereditary Cancer Panel Comprehensive panel including full sequencing and copy number variant analyses of 84 genes associated with increased risk of hereditary breast, ovarian, uterine, colorectal, gastric, prostate, melanoma, and pancreatic cancer.
- PSA (Prostate-Specific Antigen) Test A simple blood test that helps assess a man's risk of prostate cancer. One in eight men in Canada will be diagnosed with prostate cancer in their lifetime. Available at LifeLabs Patient Service Centres and via online purchase.
- Fecal Immunochemical Test (FIT) A safe, painless, stool-based screening test for people at average risk of developing colorectal cancer, checking for the presence of occult blood as an early sign of colorectal cancer and/or pre-cancerous lesions. Available as a $75 patient direct kit option.
- Alzheimer's Aβ42/40 with p-tau217 Testing A portfolio of blood-based biomarker tests for Alzheimer's disease risk assessment, including p-tau217 testing for early detection of Alzheimer's disease pathology. Announced April 21, 2026.
- Electrocardiogram (ECG) An electrocardiogram (ECG/EKG) records how the heart is functioning by measuring its electrical activity through sensors placed on the chest, arms, and lower legs. A simple procedure completed in as quickly as 15 minutes at select Patient Service Centres.
- Holter Monitoring A small, lightweight wearable device that continuously records the heart rhythm for 24 hours up to 14 days, allowing physicians to determine if there are intermittent abnormalities to the heart rhythm (arrhythmias) over an extended period.
- 24-Hour Ambulatory Blood Pressure Monitoring (ABPM) A wearable device that monitors blood pressure over 24 hours at regular intervals (typically every 15–30 minutes), providing a more reliable measurement than a single office reading for clinical decision-making.
- HbA1c Diabetes Health Kit An at-home blood collection kit for HbA1c testing that tracks average blood sugar levels over the past three months to detect diabetes and prediabetes early, manage diabetes effectively, and maintain long-term health.
- Vitamin D Health (25-Hydroxy) Test A blood test measuring 25-Hydroxy Vitamin D levels to help determine if a patient has adequate vitamin D for calcium absorption, bone growth, and prevention of osteoporosis. Available as $89 patient direct kit.
- HPV Testing
Quantifiable outcome
- Over 112 million laboratory tests performed annually, serving over 9 million patients per year
- +7 more outcomes
Companies that use LifeLabs
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles6 records
LifeLabs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability3 records
Feature12 records
LifeLabs partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- University of British Columbia (MOSAIC Research Team)coreUBC's MOSAIC research team partnered with LifeLabs to advance cardiovascular health care in British Columbia using advanced heart imaging, genomics, and AI to detect early signs of heart disease and improve risk prediction. LifeLabs provides sample collection through its network of 129 patient service centres across BC, enabling easier participation for residents including those in rural and remote communities. The initiative is part of the Canadian Precision Health Initiative, funded by Genome Canada and Genome BC, which aims to build a dataset of 100,000 Canadians to advance precision medicine.
- Interior Health AuthorityminorInterior Health, in collaboration with LifeLabs and community members, formed a working group in January 2026 to preserve lab services at the Trail Community Health Centre. Services continue with workflow improvements in place and positive recruitment signs with more staff expected over the coming months. Interior Health had previously announced the blood lab would close before relenting after community pushback.
- POGO (Pediatric Oncology Group of Ontario)minorLifeLabs partnership with POGO began in 2017, providing customized care packages and treasure baskets to children undergoing cancer treatment at POGO Satellite Clinics in Ontario starting September 2025. The initiative aims to provide comfort and support to families affected by childhood cancer.
- Major Canadian EMR Vendors (Rover HIE Integration)coreLifeLabs' Rover Health Information Exchange platform is integrated with most major electronic medical record (EMR) companies in Canada, including LifeLabs' own EMR viewer Launchpad, digital health patient portal MyCareCompass, and a variety of other public and private systems. This enables digital distribution of medical information to healthcare providers across Canada.
Scale indicators20 records
Recent moves7 records
Expansion highlights6 records
LifeLabs competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights7 records
Customer concentration
LifeLabs social profiles
Digital presenceLifeLabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
LifeLabs leadership team
Management profileNumber of profiles
Profiles7 records
LifeLabs subsidiaries and ownership
Company hierarchySubsidiaries4 records
LifeLabs funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LifeLabs M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LifeLabs
What does LifeLabs do?
LifeLabs is Canada's largest community medical diagnostic laboratory network, operating 380+ Patient Service Centres and 16 state-of-the-art laboratories across Ontario, British Columbia, and Saskatchewan. The company performs over 112 million laboratory tests annually for more than 9 million patients, spanning routine clinical chemistry, hematology, microbiology, molecular diagnostics, genetic testing (NIPT, hereditary cancer panels), cardiac monitoring, and specialty oncology testing. It also operates digital health platforms (Rover HIE, eOrder, Launchpad, MyCareCompass) and serves corporate customers including hospitals, employers, long-term care facilities, and pharmaceutical companies.
Is LifeLabs a public or private company?
LifeLabs is a private company. It is classified as corporate owned and is currently operating.
When was LifeLabs founded?
LifeLabs was founded in 1998. It employs 5,001 to 10,000 people.
Where is LifeLabs based?
LifeLabs is headquartered in Toronto, Canada, in the North America region.
How does LifeLabs make money?
Five revenue lines are on record. Provincial Public Healthcare Reimbursement is the primary driver. The others are out-of-Pocket / Private Pay Testing, corporate/B2B Laboratory Services, pharmaceutical Solutions and digital Health Solutions Licensing.
Does LifeLabs have an API?
No public API is recorded for LifeLabs.
What industry is LifeLabs in?
LifeLabs's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.